pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
pharmadog news

Browse

1,570 stories matching this filter · ← front page

★ save view↓export CSV
rangeto
sort
recentoldestsourcealpha
source
STAT979Endpoints752BioPharma Dive287BioSpace188Fierce Biotech182onclive165globenewswire health73raps66
therapy area
allOncology5737Rare Disease1267Cardiology1065Immunology966Hematology952Pulmonology848Vaccines
  • STAT+: Advocacy groups petition FDA to withdraw approval of ‘unsafe’ use of antibiotics given to livestock
    More than 60 organizations are urging the FDA to withdraw approval for what they called the “unsafe” use of antibiotics for preventing disease in food-producing livestock.
    STAT · 2mo ago↗ source
  • Jazz zeroes in on next-gen T cell engagers with AbCellera deal
    The potentially $4 billion collaboration is the latest example of drugmakers working to broaden the use of T cell engagers, which, so far, have had limited success outside of certain blood cancers.
    BioPharma Dive · 2mo ago↗ source
  • STAT+: FDA appears open to Moderna’s flu vaccine ahead of adcomm
    UniQure will submit Huntington's therapy for approval, Eli Lilly buys 4E Therapeutics, and more biotech news
← prev
page 32 of 63
next →
fda recalls43
fda medwatch32
fda press25
826
Psychiatry & CNS698
Ophthalmology394
Pain347
Endocrinology & Metabolism343
Infectious Disease336
STAT · 2mo ago
↗ source
  • STAT+: Pharmalittle: We’re reading about hackers extorting Novo, an FDA about-face, and more
    A cyber extortion group claimed ​to have stolen more than a terabyte of data from Novo Nordisk and said it is ‌exploring selling some of the data
    STAT · 2mo ago↗ source
  • STAT+: Is Abridge’s ‘patient centered’ claim a bridge too far?
    In this edition of AI Prognosis, Brittany Trang takes a close look at ambient scribe developer Abridge's claim about being patient-centered.
    STAT · 2mo ago↗ source
  • Trump administration will bring special ed to HHS
    Infant mortality rate dips, OTC naloxone options rise, and other health news from Morning Rounds
    STAT · 2mo ago↗ source
  • STAT+: Following dispute with FDA, UniQure is cleared to submit Huntington’s treatment for approval
    The FDA has reversed its opposition to a closely watched experimental treatment for Huntington’s disease, clearing a path for its maker.
    STAT · 2mo ago↗ source
  • A new Westlake-backed biotech takes aim at migraines
    Vedana Therapeutics emerged from stealth Wednesday with $46 million to support its mission of developing “anti-PACAP” therapies, an increasingly popular strategy for migraine prevention.
    BioPharma Dive · 2mo ago↗ source
  • Opinion: As a physician, I have never been more concerned about rates of congenital syphilis
    “As a physician and former public health official, I have never been more concerned about those rates of congenital syphilis,” writes Jeffrey D. Klausner.
    STAT · 2mo ago↗ source
  • Opinion: The quiet joy of being an oncologist
    “The privilege of oncology is not only that you get to cure people,” writes oncologist Khushali Jhaveri. “It is also that you are invited into the most honest rooms in…
    STAT · 2mo ago↗ source
  • Opinion: How STAT decided to keep ‘health care’ as two words
    “‘Health care’ is such a big word for STAT. It’s a cornerstone of our coverage,” says STAT director of editorial operations Sarah Mupo.
    STAT · 2mo ago↗ source
  • STAT+: A prominent VC explains why she’s against U.S. restrictions on investment in China’s drug industry
    Should the federal government try to slow — or even block — U.S. biotech deals that could benefit China?
    STAT · 2mo ago↗ source
  • STAT+: How a biotech turned a trial failure into an AI model
    In this edition of STAT Health Tech: How a biotech startup turned a failed clinical trial into an AI model, and more.
    STAT · 2mo ago↗ source
  • Lilly buys non-opioid pain drugmaker 4E
    It’s the latest in a string of deals for Lilly, which has sunk more than $18 billion into acquisitions over the past few years.
    BioPharma Dive · 2mo ago↗ source
  • Express Scripts, PCMA sue to block Tennesee law breaking up PBMs and pharmacies
    Express Scripts and the PBM lobby are following in CVS Caremark’s footsteps in filing complaints challenging the FAIR Rx Act, which was passed earlier this year despite vehement opposition from PBMs.
    BioPharma Dive · 2mo ago↗ source
  • FDA staff scrutinizes evidence supporting Moderna’s flu vaccine
    Ahead of a Thursday advisory panel meeting, agency scientists highlighted shortcomings in data accrued for a vaccine the FDA controversially refused to even review earlier this year.
    BioPharma Dive · 2mo ago↗ source
  • The U.S. infant mortality rate fell to an all-time low, though it still trails other similar nations
    Infant mortality in the U.S. dropped to a new all-time low in 2025, according to CDC data, though it still trails other similar nations.
    STAT · 2mo ago↗ source
  • STAT+: ARCH-launched Neumora stops depression program
    A new AI model to improve trial enrollment, importing drugs from Canada, and more biotech news from The Readout
    STAT · 2mo ago↗ source
  • Edgewise heart drug passes key trial test
    Still, the results leave somewhat unclear how different the company’s drug is than marketed hypertrophic cardiomyopathy medicines from Bristol Myers Squibb and Cytokinetics.
    BioPharma Dive · 2mo ago↗ source
  • STAT+: Pharmalittle: We’re reading about Medicare and obesity drugs, Germany’s pricing plans, and more
    Weight loss drugs will be available through Medicare starting next month, thanks to a program that is supposed to be temporary but may be difficult to end
    STAT · 2mo ago↗ source
  • Neumora depression drug fails; EnGene to cut 50% of staff
    Neumora’s stumble is the latest setback for a once-promising class of brain drugs. Elsewhere, a cell therapy manufacturing specialist took steps toward an IPO and J&J made its latest U.S investment.
    BioPharma Dive · 2mo ago↗ source
  • How supplement use changed over decades
    Medicare-funded weight loss, Utah's lower drunk driving limit, and more health news from Morning Rounds
    STAT · 2mo ago↗ source
  • STAT+: Verge Labs’ new AI model solves patient stratification problems for neurology clinical trials
    As the saying goes, one man’s trash is another man’s treasure. Or as Verge Labs might put it, one company’s failed clinical trial … is that same company’s new AI…
    STAT · 2mo ago↗ source
  • Opinion: I’m an Alzheimer’s specialist. I still missed it in my own father
    “Alzheimer’s is not primarily a disease of old age. It is a decades-long biological process,” writes Elizabeth Bevins.
    STAT · 2mo ago↗ source
  • Opinion: Congress must reauthorize the Pandemic and All-Hazards Preparedness Act
    America’s next health emergency won’t wait for Washington, write W. Craig Vanderwagen and Jennifer B. Alton.
    STAT · 2mo ago↗ source